TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T61792	Multidrug resistance-associated protein 2	D00BCP	Chlorpropamide	Approved	2727	C10H13ClN2O3S	276.74	CCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)Cl	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D00DKK	Isotretinoin	Approved	5282379	C20H28O2	300.4	CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C\\C(=O)O)/C)/C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D00FGO	Melphalan	Approved	460612	C13H18Cl2N2O2	305.2	C1=CC(=CC=C1C[C@@H](C(=O)O)N)N(CCCl)CCCl	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D00IBN	Piroxicam	Approved	54676228	C15H13N3O4S	331.3	CN1C(=C(C2=CC=CC=C2S1(=O)=O)O)C(=O)NC3=CC=CC=N3	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D00KVO	Albendazole	Approved	2082	C12H15N3O2S	265.33	CCCSC1=CC2=C(C=C1)N=C(N2)NC(=O)OC	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D00MIN	Propylthiouracil	Approved	657298	C7H10N2OS	170.23	CCCC1=CC(=O)NC(=S)N1	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D00NKB	Triamterene	Approved	5546	C12H11N7	253.26	C1=CC=C(C=C1)C2=NC3=C(N=C(N=C3N=C2N)N)N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D00WAM	Hydroflumethiazide	Approved	3647	C8H8F3N3O4S2	331.3	C1NC2=C(C=C(C(=C2)C(F)(F)F)S(=O)(=O)N)S(=O)(=O)N1	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D00WUF	Pregabalin	Approved	5486971	C8H17NO2	159.23	CC(C)C[C@@H](CC(=O)O)CN	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D00XUN	Etidronate Disodium	Approved	23894	C2H6Na2O7P2	249.99	CC(O)(P(=O)(O)[O-])P(=O)(O)[O-].[Na+].[Na+]	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D00YZA	Thiotepa	Approved	5453	C6H12N3PS	189.22	C1CN1P(=S)(N2CC2)N3CC3	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D00YZD	Dolutegravir	Approved	54726191	C20H19F2N3O5	419.4	C[C@@H]1CCO[C@@H]2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O	IC50 ~ 90000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D01AZG	Risperidone	Approved	5073	C23H27FN4O2	410.5	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D01DBQ	Teniposide	Approved	452548	C32H32O13S	656.7	COC1=CC(=CC(=C1O)OC)[C@H]2[C@@H]3[C@H](COC3=O)[C@@H](C4=CC5=C(C=C24)OCO5)O[C@H]6[C@@H]([C@H]([C@H]7[C@H](O6)CO[C@H](O7)C8=CC=CS8)O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D01GBY	Desloratadine	Approved	124087	C19H19ClN2	310.8	C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D01KKQ	Raltitrexed	Approved	135400182	C21H22N4O6S	458.5	CC1=NC2=C(C=C(C=C2)CN(C)C3=CC=C(S3)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N1	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D01MDT	Tizanidine	Approved	5487	C9H8ClN5S	253.71	C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D01MUR	Brinzolamide	Approved	68844	C12H21N3O5S3	383.5	CCN[C@H]1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D01OXI	DTI-015	Approved	2578	C5H9Cl2N3O2	214.05	C(CCl)NC(=O)N(CCCl)N=O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D01STB	Ramipril	Approved	5362129	C23H32N2O5	416.5	CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2[C@H]3CCC[C@H]3C[C@H]2C(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D01UTL	Desipramine	Approved	2995	C18H22N2	266.4	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D01UXC	Atenolol	Approved	2249	C14H22N2O3	266.34	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D01XNB	Omeprazole	Approved	4594	C17H19N3O3S	345.4	CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D01XYJ	Zidovudine	Approved	35370	C10H13N5O4	267.24	CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)N=[N+]=[N-]	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D01ZII	Chlorpromazine	Approved	2726	C17H19ClN2S	318.9	CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D01ZSO	Moclobemide	Approved	4235	C13H17ClN2O2	268.74	C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D02DGU	Tretinoin	Approved	444795	C20H28O2	300.4	CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D02DPA	Cimetidine	Approved	2756	C10H16N6S	252.34	CC1=C(N=CN1)CSCCNC(=NC)NC#N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D02HED	Perphenazine	Approved	4748	C21H26ClN3OS	404	C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D02LCR	Tiapride	Approved	5467	C15H24N2O4S	328.4	CCN(CC)CCNC(=O)C1=C(C=CC(=C1)S(=O)(=O)C)OC	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D02NTO	Tolnaftate	Approved	5510	C19H17NOS	307.4	CC1=CC(=CC=C1)N(C)C(=S)OC2=CC3=CC=CC=C3C=C2	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D02STN	ABIRATERONE	Approved	132971	C24H31NO	349.5	C[C@]12CC[C@@H](CC1=CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC=C4C5=CN=CC=C5)C)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D02TLO	Ifosfamide	Approved	3690	C7H15Cl2N2O2P	261.079	C1CN(P(=O)(OC1)NCCCl)CCCl	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D02YIZ	Erythromycin	Approved	12560	C37H67NO13	733.9	CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D03CQE	Gatifloxacin	Approved	5379	C19H22FN3O4	375.4	CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D03DDR	Quinine	Approved	3034034	C20H24N2O2	324.4	COC1=CC2=C(C=CN=C2C=C1)[C@H]([C@@H]3C[C@@H]4CCN3C[C@@H]4C=C)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D03ELL	Amisulpride	Approved	2159	C17H27N3O4S	369.5	CCN1CCCC1CNC(=O)C2=CC(=C(C=C2OC)N)S(=O)(=O)CC	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D03HJK	Zithromax	Approved	447043	C38H72N2O12	749	CC[C@@H]1[C@@]([C@@H]([C@H](N(C[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D03JSJ	Mupirocin	Approved	446596	C26H44O9	500.6	C[C@H]([C@H]1[C@@H](O1)C[C@H]2CO[C@H]([C@@H]([C@@H]2O)O)C/C(=C/C(=O)OCCCCCCCCC(=O)O)/C)[C@H](C)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D03KOZ	Epalrestat	Approved	1549120	C15H13NO3S2	319.4	C/C(=C\\C1=CC=CC=C1)/C=C\\2/C(=O)N(C(=S)S2)CC(=O)O	IC50 = 84400 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D03KQF	Maprotiline	Approved	4011	C20H23N	277.4	CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D03KZM	Tolvaptan	Approved	216237	C26H25ClN2O3	448.9	CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D03NHW	Ofloxacin	Approved	4583	C18H20FN3O4	361.4	CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D03QGM	Sulpiride	Approved	688272	C15H23N3O4S	341.4	CCN1CCC[C@H]1CNC(=O)C2=C(C=CC(=C2)S(=O)(=O)N)OC	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D03QWT	Doripenem	Approved	73303	C15H24N4O6S2	420.5	C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)CNS(=O)(=O)N)C(=O)O)[C@@H](C)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D03VPC	Cilostazol	Approved	2754	C20H27N5O2	369.5	C1CCC(CC1)N2C(=NN=N2)CCCCOC3=CC4=C(C=C3)NC(=O)CC4	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D03XOC	Trilostane	Approved	656583	C20H27NO3	329.4	C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CC[C@]45[C@@]3(CC(=C([C@H]4O5)O)C#N)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D03YLZ	Thiamphenicol	Approved	27200	C12H15Cl2NO5S	356.2	CS(=O)(=O)C1=CC=C(C=C1)[C@H]([C@@H](CO)NC(=O)C(Cl)Cl)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D04AAW	Cidofovir	Approved	60613	C8H14N3O6P	279.19	C1=CN(C(=O)N=C1N)C[C@@H](CO)OCP(=O)(O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D04EGX	Cabergoline	Approved	54746	C26H37N5O2	451.6	CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](CC3=CNC4=CC=CC2=C34)N(C1)CC=C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D04FBR	Mycophenolate mofetil	Approved	5281078	C23H31NO7	433.5	CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\\C)/CCC(=O)OCCN3CCOCC3)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D04JCN	Pergolide	Approved	47811	C19H26N2S	314.5	CCCN1C[C@@H](C[C@H]2[C@H]1CC3=CNC4=CC=CC2=C34)CSC	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D04JPJ	Lomustine	Approved	3950	C9H16ClN3O2	233.69	C1CCC(CC1)NC(=O)N(CCCl)N=O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D04KYY	Allopurinol	Approved	135401907	C5H4N4O	136.11	.	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D04MSM	Carbamazepine	Approved	2554	C15H12N2O	236.27	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D04NXQ	Pefloxacin	Approved	51081	C17H20FN3O3	333.36	CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCN(CC3)C)F)C(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D04OSE	Nifedipine	Approved	4485	C17H18N2O6	346.3	CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D04RGA	Dinoprost Tromethamine	Approved	5282415	C24H45NO8	475.6	CCCCC[C@@H](/C=C/[C@H]1[C@@H](C[C@@H]([C@@H]1C/C=C\\CCCC(=O)O)O)O)O.C(C(CO)(CO)N)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D04VMT	Sotalol	Approved	5253	C12H20N2O3S	272.37	CC(C)NCC(C1=CC=C(C=C1)NS(=O)(=O)C)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D04WFD	Nortriptyline	Approved	4543	C19H21N	263.4	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D04XGT	Benznidazole	Approved	31593	C12H12N4O3	260.25	C1=CC=C(C=C1)CNC(=O)CN2C=CN=C2[N+](=O)[O-]	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D04YMH	Lumiracoxib	Approved	151166	C15H13ClFNO2	293.72	CC1=CC(=C(C=C1)NC2=C(C=CC=C2Cl)F)CC(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D04ZTY	Voglibose	Approved	444020	C10H21NO7	267.28	C1[C@@H]([C@@H]([C@H]([C@@H]([C@]1(CO)O)O)O)O)NC(CO)CO	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D05ARP	Ganciclovir	Approved	135398740	C9H13N5O4	255.23	C1=NC2=C(N1COC(CO)CO)N=C(NC2=O)N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D05DVP	Zafirlukast	Approved	5717	C31H33N3O6S	575.7	CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC	IC50 = 58800 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D05EAM	Pentamidine	Approved	4735	C19H24N4O2	340.4	C1=CC(=CC=C1C(=N)N)OCCCCCOC2=CC=C(C=C2)C(=N)N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D05FTJ	Mefenamic acid	Approved	4044	C15H15NO2	241.28	CC1=C(C(=CC=C1)NC2=CC=CC=C2C(=O)O)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D05GJW	Cladribine	Approved	20279	C10H12ClN5O3	285.69	C1[C@@H]([C@H](O[C@H]1N2C=NC3=C(N=C(N=C32)Cl)N)CO)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D05HSC	Tubocurarine	Approved	6000	C37H41N2O6+	609.7	CN1CCC2=CC(=C3C=C2[C@@H]1CC4=CC=C(C=C4)OC5=C6[C@@H](CC7=CC(=C(C=C7)O)O3)[N+](CCC6=CC(=C5O)OC)(C)C)OC	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D05LEO	Fluorouracil	Approved	3385	C4H3FN2O2	130.08	C1=C(C(=O)NC(=O)N1)F	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D05LKP	Sulfadiazine	Approved	5215	C10H10N4O2S	250.28	C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D05MFA	Valacyclovir Hydrochloride	Approved	135398741	C13H21ClN6O4	360.8	.	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D05MQK	Tadalafil	Approved	110635	C22H19N3O4	389.4	CN1CC(=O)N2[C@@H](C1=O)CC3=C([C@H]2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D05OFX	Lacosamide	Approved	219078	C13H18N2O3	250.29	CC(=O)N[C@H](COC)C(=O)NCC1=CC=CC=C1	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D05UVD	Timolol	Approved	33624	C13H24N4O3S	316.42	CC(C)(C)NC[C@@H](COC1=NSN=C1N2CCOCC2)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D05VIL	Nalmefene	Approved	5284594	C21H25NO3	339.4	C=C1CC[C@]2([C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)O)CCN3CC6CC6)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D05VLS	Rofecoxib	Approved	5090	C17H14O4S	314.4	CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D05ZGQ	Dexchlorpheniramine Maleate	Approved	5281070	C20H23ClN2O4	390.9	CN(C)CC[C@@H](C1=CC=C(C=C1)Cl)C2=CC=CC=N2.C(=C\\C(=O)O)\\C(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D05ZIK	Mirtazapine	Approved	4205	C17H19N3	265.35	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D06ABF	Loratadine	Approved	3957	C22H23ClN2O2	382.9	CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D06BEP	Chlordiazepoxide	Approved	2712	C16H14ClN3O	299.75	CN=C1CN(C(=C2C=C(C=CC2=N1)Cl)C3=CC=CC=C3)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D06CTE	Imiquimod	Approved	57469	C14H16N4	240.3	CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D06GAM	Fleroxacin	Approved	3357	C17H18F3N3O3	369.34	CN1CCN(CC1)C2=C(C=C3C(=C2F)N(C=C(C3=O)C(=O)O)CCF)F	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D06NXY	Ethinyl Estradiol	Approved	5991	C20H24O2	296.4	C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=C3C=CC(=C4)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D06OIV	Tolbutamide	Approved	5505	C12H18N2O3S	270.35	CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D06OVY	Cefixime	Approved	5362065	C16H15N5O7S2	453.5	C=CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\\OCC(=O)O)/C3=CSC(=N3)N)SC1)C(=O)O	IC50 = 89400 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D06PSS	Nateglinide	Approved	5311309	C19H27NO3	317.4	CC(C)C1CCC(CC1)C(=O)N[C@H](CC2=CC=CC=C2)C(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D06VML	Seroxat	Approved	43815	C19H20FNO3	329.4	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D06WTZ	Lovastatin	Approved	53232	C24H36O5	404.5	CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D06XAE	Drotaverine	Approved	1712095	C24H31NO4	397.5	CCOC1=C(C=C(C=C1)/C=C\\2/C3=CC(=C(C=C3CCN2)OCC)OCC)OCC	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D06XMU	Testosterone	Approved	6013	C19H28O2	288.4	C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D06YYD	Dexlansoprazole	Approved	9578005	C16H14F3N3O2S	369.4	CC1=C(C=CN=C1C[S@@](=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D06ZII	Eszopiclone	Approved	969472	C17H17ClN6O3	388.8	CN1CCN(CC1)C(=O)O[C@H]2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D06ZUK	Imipramine	Approved	3696	C19H24N2	280.4	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D07CWD	Hydroxyurea	Approved	3657	CH4N2O2	76.055	C(=O)(N)NO	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D07HGR	Lisinopril	Approved	5362119	C21H31N3O5	405.5	C1C[C@H](N(C1)C(=O)[C@H](CCCCN)N[C@@H](CCC2=CC=CC=C2)C(=O)O)C(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D07HVY	Efavirenz	Approved	64139	C14H9ClF3NO2	315.67	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D07IEF	Bisacodyl	Approved	2391	C22H19NO4	361.4	CC(=O)OC1=CC=C(C=C1)C(C2=CC=C(C=C2)OC(=O)C)C3=CC=CC=N3	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D07JGT	Nalidixic Acid	Approved	4421	C12H12N2O3	232.23	CCN1C=C(C(=O)C2=C1N=C(C=C2)C)C(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D07KSG	Tamoxifen	Approved	2733526	C26H29NO	371.5	CC/C(=C(\\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D07QCE	Azathioprine	Approved	2265	C9H7N7O2S	277.27	CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D07SUG	Busulfan	Approved	2478	C6H14O6S2	246.3	CS(=O)(=O)OCCCCOS(=O)(=O)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D07TQV	Lamivudine	Approved	60825	C8H11N3O3S	229.26	C1[C@H](O[C@H](S1)CO)N2C=CC(=NC2=O)N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D07UYO	Linezolid	Approved	441401	C16H20FN3O4	337.35	CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D07VDZ	Topiramate	Approved	5284627	C12H21NO8S	339.36	CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D07VLY	Doxorubicin	Approved	31703	C27H29NO11	543.5	C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D07WEP	Diazoxide	Approved	3019	C8H7ClN2O2S	230.67	CC1=NS(=O)(=O)C2=C(N1)C=CC(=C2)Cl	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D07XGR	Fenofibrate	Approved	3339	C20H21ClO4	360.8	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D07XSN	Cytarabine	Approved	6253	C9H13N3O5	243.22	C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D08EBN	Nitazoxanide	Approved	41684	C12H9N3O5S	307.28	CC(=O)OC1=CC=CC=C1C(=O)NC2=NC=C(S2)[N+](=O)[O-]	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D08HVR	Levodopa	Approved	6047	C9H11NO4	197.19	C1=CC(=C(C=C1C[C@@H](C(=O)O)N)O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D08IWD	Finasteride	Approved	57363	C23H36N2O2	372.5	C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NC(C)(C)C)CC[C@@H]4[C@@]3(C=CC(=O)N4)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D08JIV	Amlodipine	Approved	2162	C20H25ClN2O5	408.9	CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D08PIQ	Methylprednisolone	Approved	6741	C22H30O5	374.5	C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D08QIP	Pranlukast	Approved	4887	C27H23N5O4	481.5	C1=CC=C(C=C1)CCCCOC2=CC=C(C=C2)C(=O)NC3=CC=CC4=C3OC(=CC4=O)C5=NNN=N5	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D08ROP	Leflunomide	Approved	3899	C12H9F3N2O2	270.21	CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D08USJ	Neostigmine	Approved	4456	C12H19N2O2+	223.29	CN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D08VRO	Ketanserin	Approved	3822	C22H22FN3O3	395.4	C1CN(CCC1C(=O)C2=CC=C(C=C2)F)CCN3C(=O)C4=CC=CC=C4NC3=O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D08VXL	Molsidomine	Approved	5353788	C9H14N4O4	242.23	CCO/C(=N/C1=C[N+](=NO1)N2CCOCC2)/[O-]	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D08VYV	Metoclopramide	Approved	4168	C14H22ClN3O2	299.79	CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D08ZEB	Chlorzoxazone	Approved	2733	C7H4ClNO2	169.56	C1=CC2=C(C=C1Cl)NC(=O)O2	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D09CZA	Travoprost	Approved	5282226	C26H35F3O6	500.5	CC(C)OC(=O)CCC/C=C\\C[C@H]1[C@H](C[C@H]([C@@H]1/C=C/[C@H](COC2=CC=CC(=C2)C(F)(F)F)O)O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D09DWL	Zaleplon	Approved	5719	C17H15N5O	305.33	CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D09EGZ	Chloroquine	Approved	2719	C18H26ClN3	319.9	CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D09HNR	Telithromycin	Approved	3002190	C43H65N5O10	812	CC[C@@H]1[C@@]2([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H](C(=O)[C@H](C(=O)O1)C)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D09HVL	Bivalirudin	Approved	16129704	C98H138N24O33	2180.3	CC[C@H](C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CC(=O)N)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]5CCCN5C(=O)[C@@H](CC6=CC=CC=C6)N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D09IOI	Amoxapine	Approved	2170	C17H16ClN3O	313.8	C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D09JUG	Zileuton	Approved	60490	C11H12N2O2S	236.29	CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D09LNI	Fluconazole	Approved	3365	C13H12F2N6O	306.27	C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D09LWS	Ezetimibe	Approved	150311	C24H21F2NO3	409.4	C1=CC(=CC=C1[C@@H]2[C@H](C(=O)N2C3=CC=C(C=C3)F)CC[C@@H](C4=CC=C(C=C4)F)O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D09MGR	Etoricoxib	Approved	123619	C18H15ClN2O2S	358.8	CC1=NC=C(C=C1)C2=C(C=C(C=N2)Cl)C3=CC=C(C=C3)S(=O)(=O)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D09NIA	Chlorthalidone	Approved	2732	C14H11ClN2O4S	338.8	C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D09TBD	Sulfisoxazole	Approved	5344	C11H13N3O3S	267.31	CC1=C(ON=C1C)NS(=O)(=O)C2=CC=C(C=C2)N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D09XQF	Isoniazid	Approved	3767	C6H7N3O	137.14	C1=CN=CC=C1C(=O)NN	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0A0OO	Amprenavir	Approved	65016	C25H35N3O6S	505.6	CC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)O)S(=O)(=O)C3=CC=C(C=C3)N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0A2ZX	Metronidazole	Approved	4173	C6H9N3O3	171.15	CC1=NC=C(N1CCO)[N+](=O)[O-]	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0A5SE	Febuxostat	Approved	134018	C16H16N2O3S	316.4	CC1=C(SC(=N1)C2=CC(=C(C=C2)OCC(C)C)C#N)C(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0A9YA	Dutasteride	Approved	6918296	C27H30F6N2O2	528.5	C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CC[C@@H]5[C@@]3(C=CC(=O)N5)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0AA2D	Bifonazole	Approved	2378	C22H18N2	310.4	C1=CC=C(C=C1)C2=CC=C(C=C2)C(C3=CC=CC=C3)N4C=CN=C4	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0AD5C	Acarbose	Approved	41774	C25H43NO18	645.6	C[C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@@H]2[C@H](O[C@@H]([C@@H]([C@H]2O)O)O[C@@H]3[C@H](OC([C@@H]([C@H]3O)O)O)CO)CO)O)O)N[C@H]4C=C([C@H]([C@@H]([C@H]4O)O)O)CO	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0AO5H	Trimethoprim	Approved	5578	C14H18N4O3	290.32	COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0AP9T	Cefotetan	Approved	53025	C17H17N7O8S4	575.6	CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@](C3=O)(NC(=O)C4SC(=C(C(=O)N)C(=O)O)S4)OC)SC2)C(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0AV3G	Domperidone	Approved	3151	C22H24ClN5O2	425.9	C1CN(CCC1N2C3=C(C=C(C=C3)Cl)NC2=O)CCCN4C5=CC=CC=C5NC4=O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0AZ3C	Imatinib	Approved	5291	C29H31N7O	493.6	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0B1IP	Etretinate	Approved	5282375	C23H30O3	354.5	CCOC(=O)/C=C(\\C)/C=C/C=C(\\C)/C=C/C1=C(C(=C(C=C1C)OC)C)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0B2UZ	Prochlorperazine	Approved	4917	C20H24ClN3S	373.9	CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0B4IF	Ketoconazole	Approved	3823	C26H28Cl2N4O4	531.4	CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0B5MP	Aciclovir	Approved	135398513	C8H11N5O3	225.2	C1=NC2=C(N1COCCO)N=C(NC2=O)N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0B6TW	Leucovorin Calcium	Approved	135403647	C20H21CaN7O7	511.5	.	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0B7EB	Etoposide	Approved	36462	C29H32O13	588.6	C[C@@H]1OC[C@@H]2[C@@H](O1)[C@@H]([C@H]([C@@H](O2)O[C@H]3[C@H]4COC(=O)[C@@H]4[C@@H](C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0B8UJ	Nelarabine	Approved	3011155	C11H15N5O5	297.27	COC1=NC(=NC2=C1N=CN2[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0C3YQ	Mesna	Approved	23662354	C2H5NaO3S2	164.18	C(CS(=O)(=O)[O-])S.[Na+]	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0C8EU	Temozolomide	Approved	5394	C6H6N6O2	194.15	CN1C(=O)N2C=NC(=C2N=N1)C(=O)N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0CL9S	Telbivudine	Approved	159269	C10H14N2O5	242.23	CC1=CN(C(=O)NC1=O)[C@@H]2C[C@H]([C@@H](O2)CO)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0CT9C	Cyclophosphamide	Approved	2907	C7H15Cl2N2O2P	261.079	C1CNP(=O)(OC1)N(CCCl)CCCl	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0CW1P	Betamethasone	Approved	9782	C22H29FO5	392.5	C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0D0ZD	Miglitol	Approved	441314	C8H17NO5	207.22	C1[C@@H]([C@H]([C@@H]([C@H](N1CCO)CO)O)O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0D1AL	Haloperidol	Approved	3559	C21H23ClFNO2	375.9	C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0D1SG	Prednisolone	Approved	5755	C21H28O5	360.4	C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0D2VS	Exemestane	Approved	60198	C20H24O2	296.4	C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC(=C)C4=CC(=O)C=C[C@]34C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0D5GD	Flumazenil	Approved	3373	C15H14FN3O3	303.29	CCOC(=O)C1=C2CN(C(=O)C3=C(N2C=N1)C=CC(=C3)F)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0D5GG	Pemoline	Approved	4723	C9H8N2O2	176.17	.	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0D7KC	Alvimopan	Approved	5488548	C25H32N2O4	424.5	C[C@H]1CN(CC[C@@]1(C)C2=CC(=CC=C2)O)C[C@H](CC3=CC=CC=C3)C(=O)NCC(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0DJ1B	Naproxen	Approved	156391	C14H14O3	230.26	C[C@@H](C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0E0SW	Enoximone	Approved	53708	C12H12N2O2S	248.3	CC1=C(NC(=O)N1)C(=O)C2=CC=C(C=C2)SC	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0E1SW	Acetazolamide	Approved	1986	C4H6N4O3S2	222.3	CC(=O)NC1=NN=C(S1)S(=O)(=O)N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0E1XL	Levetiracetam	Approved	5284583	C8H14N2O2	170.21	CC[C@@H](C(=O)N)N1CCCC1=O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0E6OC	Tranilast	Approved	5282230	C18H17NO5	327.3	COC1=C(C=C(C=C1)/C=C/C(=O)NC2=CC=CC=C2C(=O)O)OC	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0E6XR	Dasatinib	Approved	3062316	C22H26ClN7O2S	488	CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0E6YQ	Tacrine	Approved	1935	C13H14N2	198.26	C1CCC2=NC3=CC=CC=C3C(=C2C1)N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0E7PQ	Vorinostat	Approved	5311	C14H20N2O3	264.32	C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0EG1I	Tofacitinib	Approved	9926791	C16H20N6O	312.37	C[C@@H]1CCN(C[C@@H]1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0F3SY	Tegafur	Approved	288216	C8H9FN2O3	200.17	C1C[C@@H](OC1)N2C=C(C(=O)NC2=O)F	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0F6EO	Amoxicillin	Approved	33613	C16H19N3O5S	365.4	CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=C(C=C3)O)N)C(=O)O)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0F7CS	Rotenone	Approved	6758	C23H22O6	394.4	CC(=C)[C@H]1CC2=C(O1)C=CC3=C2O[C@@H]4COC5=CC(=C(C=C5[C@@H]4C3=O)OC)OC	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0F9GE	Dipyridamole	Approved	3108	C24H40N8O4	504.6	C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0G3DL	Rifampin	Approved	135398735	C43H58N4O12	822.9	.	IC50 = 53000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0G4OD	Tigecycline	Approved	54686904	C29H39N5O8	585.6	.	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0G5AG	Mizoribine	Approved	104762	C9H13N3O6	259.22	C1=NC(=C(N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)O)C(=O)N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0G5UB	Amlexanox	Approved	2161	C16H14N2O4	298.29	CC(C)C1=CC2=C(C=C1)OC3=NC(=C(C=C3C2=O)C(=O)O)N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0G6CT	Levonorgestrel	Approved	13109	C21H28O2	312.4	CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0G8NN	Pramipexole	Approved	119570	C10H17N3S	211.33	CCCN[C@H]1CCC2=C(C1)SC(=N2)N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0G9YH	Amsacrine	Approved	2179	C21H19N3O3S	393.5	COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC=CC3=NC4=CC=CC=C42	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0GU4K	Aprepitant	Approved	135413536	C23H21F7N4O3	534.4	.	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0GY5Z	Aspirin	Approved	2244	C9H8O4	180.16	CC(=O)OC1=CC=CC=C1C(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0H0KB	Riluzole	Approved	5070	C8H5F3N2OS	234.2	C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0H0ND	Simvastatin	Approved	54454	C25H38O5	418.6	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0H3HM	Aripiprazole	Approved	60795	C23H27Cl2N3O2	448.4	C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0H3WI	Ribavirin	Approved	37542	C8H12N4O5	244.2	C1=NC(=NN1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)C(=O)N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0H6QU	Apomorphine	Approved	6005	C17H17NO2	267.32	CN1CCC2=C3[C@H]1CC4=C(C3=CC=C2)C(=C(C=C4)O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0H8FH	Indapamide	Approved	3702	C16H16ClN3O3S	365.8	CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0I0EG	Captopril	Approved	44093	C9H15NO3S	217.29	C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0I2MK	Metoprolol	Approved	4171	C15H25NO3	267.36	CC(C)NCC(COC1=CC=C(C=C1)CCOC)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0I4DQ	Alprostadil	Approved	5280723	C20H34O5	354.5	CCCCC[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1CCCCCCC(=O)O)O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0I6IB	Tenoxicam	Approved	54677971	C13H11N3O4S2	337.4	.	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0IT2X	Carprofen	Approved	2581	C15H12ClNO2	273.71	CC(C1=CC2=C(C=C1)C3=C(N2)C=CC(=C3)Cl)C(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0J1MI	Mebendazole	Approved	4030	C16H13N3O3	295.29	COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C3=CC=CC=C3	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0J1VY	Entacapone	Approved	5281081	C14H15N3O5	305.29	CCN(CC)C(=O)/C(=C/C1=CC(=C(C(=C1)O)O)[N+](=O)[O-])/C#N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0J2KV	Propafenone	Approved	4932	C21H27NO3	341.4	CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0J2MJ	Selegiline Hydrochloride	Approved	26758	C13H18ClN	223.74	C[C@H](CC1=CC=CC=C1)N(C)CC#C.Cl	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0J4JM	Reserpine	Approved	5770	C33H40N2O9	608.7	CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C([C@H]3C[C@@H]2[C@@H]1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	IC50 = 68400 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0J5DC	Clofibrate	Approved	2796	C12H15ClO3	242.7	CCOC(=O)C(C)(C)OC1=CC=C(C=C1)Cl	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0JO7Y	Fulvestrant	Approved	104741	C32H47F5O3S	606.8	C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)[C@@H](CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0K0OZ	Famotidine	Approved	5702160	C8H15N7O2S3	337.5	C1=C(N=C(S1)N=C(N)N)CSCC/C(=N/S(=O)(=O)N)/N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0K0VO	Urapidil	Approved	5639	C20H29N5O3	387.5	CN1C(=CC(=O)N(C1=O)C)NCCCN2CCN(CC2)C3=CC=CC=C3OC	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0K3MC	Lofepramine	Approved	3947	C26H27ClN2O	419	CN(CCCN1C2=CC=CC=C2CCC3=CC=CC=C31)CC(=O)C4=CC=C(C=C4)Cl	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0K5CB	Salbutamol	Approved	2083	C13H21NO3	239.31	CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0K6GZ	Sparfloxacin	Approved	60464	C19H22F2N4O3	392.4	C[C@@H]1CN(C[C@@H](N1)C)C2=C(C(=C3C(=C2F)N(C=C(C3=O)C(=O)O)C4CC4)N)F	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0K7HU	Ciclesonide	Approved	6918155	C32H44O7	540.7	CC(C)C(=O)OCC(=O)[C@@]12[C@@H](C[C@@H]3[C@@]1(C[C@@H]([C@H]4[C@H]3CCC5=CC(=O)C=C[C@]45C)O)C)O[C@H](O2)C6CCCCC6	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0K7WK	Ondansetron	Approved	4595	C18H19N3O	293.4	CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0KR2J	Entecavir	Approved	135398508	C12H15N5O3	277.28	.	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0L3DK	Vildagliptin	Approved	6918537	C17H25N3O2	303.4	C1C[C@H](N(C1)C(=O)CNC23CC4CC(C2)CC(C4)(C3)O)C#N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0L3MP	VRX496	Approved	64143	C32H45N3O4S	567.8	CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@@H](CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0L5RW	Plerixafor	Approved	65015	C28H54N8	502.8	C1CNCCNCCCN(CCNC1)CC2=CC=C(C=C2)CN3CCCNCCNCCCNCC3	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0L5WM	Amiodarone	Approved	2157	C25H29I2NO3	645.3	CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCCN(CC)CC)I	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0L6DA	Valdecoxib	Approved	119607	C16H14N2O3S	314.4	CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0L7FM	Probenecid	Approved	4911	C13H19NO4S	285.36	CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0L9ZR	Praziquantel	Approved	4891	C19H24N2O2	312.4	C1CCC(CC1)C(=O)N2CC3C4=CC=CC=C4CCN3C(=O)C2	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0M2MR	Gliclazide	Approved	3475	C15H21N3O3S	323.4	CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0M3QP	Digitoxin	Approved	441207	C41H64O13	764.9	C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@]5([C@@H](C4)CC[C@@H]6[C@@H]5CC[C@]7([C@@]6(CC[C@@H]7C8=CC(=O)OC8)O)C)C)C)C)O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0M4YC	Disopyramide	Approved	3114	C21H29N3O	339.5	CC(C)N(CCC(C1=CC=CC=C1)(C2=CC=CC=N2)C(=O)N)C(C)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0M5JI	Luvox	Approved	9560989	C19H25F3N2O6	434.4	COCCCC/C(=N\\OCCN)/C1=CC=C(C=C1)C(F)(F)F.C(=C\\C(=O)O)\\C(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0M6DO	Aminoglutethimide	Approved	2145	C13H16N2O2	232.28	CCC1(CCC(=O)NC1=O)C2=CC=C(C=C2)N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0M8RC	Terbutaline	Approved	5403	C12H19NO3	225.28	CC(C)(C)NCC(C1=CC(=CC(=C1)O)O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0M8VE	Iloperidone	Approved	71360	C24H27FN2O4	426.5	CC(=O)C1=CC(=C(C=C1)OCCCN2CCC(CC2)C3=NOC4=C3C=CC(=C4)F)OC	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0M9DC	Oxaprozin	Approved	4614	C18H15NO3	293.3	C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0MA9N	Dapsone	Approved	2955	C12H12N2O2S	248.3	C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0ML1F	Adefovir Dipivoxil	Approved	60871	C20H32N5O8P	501.5	CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N=CN=C21)N)OCOC(=O)C(C)(C)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0N0RU	Bexarotene	Approved	82146	C24H28O2	348.5	CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0N3VR	Voriconazole	Approved	71616	C16H14F3N5O	349.31	C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0N4OW	Vasopressin	Approved	644077	C46H65N15O12S2	1084.2	C1C[C@H](N(C1)C(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0N5HJ	Enalaprilat	Approved	5462501	C18H24N2O5	348.4	C[C@@H](C(=O)N1CCC[C@H]1C(=O)O)N[C@@H](CCC2=CC=CC=C2)C(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0N5YA	Repaglinide	Approved	65981	C27H36N2O4	452.6	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O	IC50 = 72300 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0N6RF	Telmisartan	Approved	65999	C33H30N4O2	514.6	CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0NG7O	Zolmitriptan	Approved	60857	C16H21N3O2	287.36	CN(C)CCC1=CNC2=C1C=C(C=C2)C[C@H]3COC(=O)N3	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0NJ3V	Papaverine	Approved	4680	C20H21NO4	339.4	COC1=C(C=C(C=C1)CC2=NC=CC3=CC(=C(C=C32)OC)OC)OC	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0NR6S	Maraviroc	Approved	3002977	C29H41F2N5O	513.7	CC1=NN=C(N1C2C[C@H]3CC[C@@H](C2)N3CC[C@@H](C4=CC=CC=C4)NC(=O)C5CCC(CC5)(F)F)C(C)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0NS6H	Donepezil	Approved	3152	C24H29NO3	379.5	COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0NW3X	Dofetilide	Approved	71329	C19H27N3O5S2	441.6	CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0O1WX	Ciprofloxacin XR	Approved	2764	C17H18FN3O3	331.34	C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0O2EM	Nevirapine	Approved	4463	C15H14N4O	266.3	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0O2SR	Nicorandil	Approved	47528	C8H9N3O4	211.17	C1=CC(=CN=C1)C(=O)NCCO[N+](=O)[O-]	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0O3OS	SR141716A	Approved	104850	C22H21Cl3N4O	463.8	CC1=C(N(N=C1C(=O)NN2CCCCC2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0O4SE	Tindamax	Approved	5479	C8H13N3O4S	247.27	CCS(=O)(=O)CCN1C(=NC=C1[N+](=O)[O-])C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0O5FY	Meropenem	Approved	441130	C17H25N3O5S	383.5	C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)C(=O)N(C)C)C(=O)O)[C@@H](C)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0O5WP	Docetaxel	Approved	148124	C43H53NO14	807.9	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0OB1J	Diltiazem	Approved	39186	C22H26N2O4S	414.5	CC(=O)O[C@@H]1[C@@H](SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0OT0O	Foscavir	Approved	44561	CNa3O5P	191.95	C(=O)([O-])P(=O)([O-])[O-].[Na+].[Na+].[Na+]	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0P1UX	Venlafaxine	Approved	5656	C17H27NO2	277.4	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0P7JZ	Carbidopa	Approved	34359	C10H14N2O4	226.23	C[C@](CC1=CC(=C(C=C1)O)O)(C(=O)O)NN	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0P9RF	Terazosin	Approved	5401	C19H25N5O4	387.4	COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0PQ3G	Furosemide	Approved	3440	C12H11ClN2O5S	330.74	C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0PW7C	Cefaclor	Approved	51039	C15H14ClN3O4S	367.8	C1C(=C(N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N)C(=O)O)Cl	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0Q2PE	Norfloxacin	Approved	4539	C16H18FN3O3	319.33	CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0Q2XF	Bimatoprost	Approved	5311027	C25H37NO4	415.6	CCNC(=O)CCC/C=C\\C[C@H]1[C@H](C[C@H]([C@@H]1/C=C/[C@H](CCC2=CC=CC=C2)O)O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0Q3YO	Cinnarizine	Approved	1547484	C26H28N2	368.5	C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=CC=C3)C4=CC=CC=C4	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0Q4XQ	Ethosuximide	Approved	3291	C7H11NO2	141.17	CCC1(CC(=O)NC1=O)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0Q4YK	Piracetam	Approved	4843	C6H10N2O2	142.16	C1CC(=O)N(C1)CC(=O)N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0Q5UQ	Exjade	Approved	214348	C21H15N3O4	373.4	.	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0Q8ZX	Benzocaine	Approved	2337	C9H11NO2	165.19	CCOC(=O)C1=CC=C(C=C1)N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0QL3P	Oxcarbazepine	Approved	34312	C15H12N2O2	252.27	C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0R0BX	Nitrofurantoin	Approved	6604200	C8H6N4O5	238.16	C1C(=O)NC(=O)N1/N=C/C2=CC=C(O2)[N+](=O)[O-]	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0R0FE	Verapamil	Approved	2520	C27H38N2O4	454.6	CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0R1WR	Procyclidine	Approved	4919	C19H29NO	287.4	C1CCC(CC1)C(CCN2CCCC2)(C3=CC=CC=C3)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0R2KJ	Dicloxacillin	Approved	18381	C19H17Cl2N3O5S	470.3	CC1=C(C(=NO1)C2=C(C=CC=C2Cl)Cl)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0R3FP	Tenofovir disoproxil fumarate	Approved	6398764	C23H34N5O14P	635.5	C[C@H](CN1C=NC2=C(N=CN=C21)N)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C.C(=C/C(=O)O)\\C(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0R3QY	Vigabatrin	Approved	5665	C6H11NO2	129.16	C=CC(CCC(=O)O)N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0R5RR	Clofarabine	Approved	119182	C10H11ClFN5O3	303.68	C1=NC2=C(N=C(N=C2N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)F)Cl)N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0R6TI	Inamrinone Lactate	Approved	3698	C10H9N3O	187.2	C1=CN=CC=C1C2=CNC(=O)C(=C2)N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0R8ER	Enoxacin	Approved	3229	C15H17FN4O3	320.32	CCN1C=C(C(=O)C2=CC(=C(N=C21)N3CCNCC3)F)C(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0R9OH	Sulfamethoxazole	Approved	5329	C10H11N3O3S	253.28	CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0R9VR	Galantamine	Approved	9651	C17H21NO3	287.35	CN1CC[C@@]23C=C[C@@H](C[C@@H]2OC4=C(C=CC(=C34)C1)OC)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0S0AS	Ipratropium	Approved	3746	C20H30NO3+	332.5	CC(C)[N+]1(C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0S1NZ	Acipimox	Approved	5310993	C6H6N2O3	154.12	CC1=CN=C(C=[N+]1[O-])C(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0S4BR	Methimazole	Approved	1349907	C4H6N2S	114.17	CN1C=CNC1=S	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0S5CU	Nisoldipine	Approved	4499	C20H24N2O6	388.4	CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0S5WG	Flucytosine	Approved	3366	C4H4FN3O	129.09	C1=NC(=O)NC(=C1F)N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0S9MC	Clobazam - Lundbeck	Approved	2789	C16H13ClN2O2	300.74	CN1C(=O)CC(=O)N(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0S9SD	Emtricitabine	Approved	60877	C8H10FN3O3S	247.25	C1[C@H](O[C@H](S1)CO)N2C=C(C(=NC2=O)N)F	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0SH3I	Bortezomib	Approved	387447	C19H25BN4O4	384.2	B([C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0SV8E	Methotrexate	Approved	126941	C20H22N8O5	454.4	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0T0KA	Nicardipine	Approved	4474	C26H29N3O6	479.5	CC1=C(C(C(=C(N1)C)C(=O)OCCN(C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0T1LK	Primaquine	Approved	4908	C15H21N3O	259.35	CC(CCCN)NC1=C2C(=CC(=C1)OC)C=CC=N2	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0T2PL	Calcitriol	Approved	5280453	C27H44O3	416.6	C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](C[C@@H](C3=C)O)O)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0T2XU	Promethazine	Approved	4927	C17H20N2S	284.4	CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0T5WK	Nitrazepam	Approved	4506	C15H11N3O3	281.27	C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0T7US	Eprosartan	Approved	5281037	C23H24N2O4S	424.5	CCCCC1=NC=C(N1CC2=CC=C(C=C2)C(=O)O)/C=C(\\CC3=CC=CS3)/C(=O)O	IC50 = 57900 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0T8GD	Nicotine	Approved	89594	C10H14N2	162.23	CN1CCC[C@H]1C2=CN=CC=C2	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0T9DT	Diatrizoate	Approved	2140	C11H9I3N2O4	613.91	CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)NC(=O)C)I	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0T9TJ	Orlistat	Approved	3034010	C29H53NO5	495.7	CCCCCCCCCCC[C@@H](C[C@H]1[C@@H](C(=O)O1)CCCCCC)OC(=O)[C@H](CC(C)C)NC=O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0U0KW	Ramelteon	Approved	208902	C16H21NO2	259.339	CCC(=O)NCC[C@@H]1CCC2=C1C3=C(C=C2)OCC3	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0U2JP	Sitagliptin	Approved	4369359	C16H15F6N5O	407.31	C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)C[C@@H](CC3=CC(=C(C=C3F)F)F)N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0U4UQ	Hydrochlorothiazide	Approved	3639	C7H8ClN3O4S2	297.7	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0U5GB	Lopinavir	Approved	92727	C37H48N4O5	628.8	CC1=C(C(=CC=C1)C)OCC(=O)N[C@@H](CC2=CC=CC=C2)[C@H](C[C@H](CC3=CC=CC=C3)NC(=O)[C@H](C(C)C)N4CCCNC4=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0U5QK	Acetaminophen	Approved	1983	C8H9NO2	151.16	CC(=O)NC1=CC=C(C=C1)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0U5RT	Primidone	Approved	4909	C12H14N2O2	218.25	CCC1(C(=O)NCNC1=O)C2=CC=CC=C2	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0U5SI	Procainamide	Approved	4913	C13H21N3O	235.33	CCN(CC)CCNC(=O)C1=CC=C(C=C1)N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0UF6M	Thiacetazone	Approved	9568512	C10H12N4OS	236.3	CC(=O)NC1=CC=C(C=C1)/C=N/NC(=S)N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0UL2L	Lornoxicam	Approved	54690031	C13H10ClN3O4S2	371.8	CN1C(=C(C2=C(S1(=O)=O)C=C(S2)Cl)O)C(=O)NC3=CC=CC=N3	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0UM7O	Ketamine	Approved	3821	C13H16ClNO	237.72	CNC1(CCCCC1=O)C2=CC=CC=C2Cl	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0V4QS	Olanzapine	Approved	135398745	C17H20N4S	312.4	.	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0V7CF	Indinavir	Approved	5362440	C36H47N5O4	613.8	CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@H](C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@@H](CC4=CC=CC=C34)O)O)CC5=CN=CC=C5	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0V8QT	Chlorambucil	Approved	2708	C14H19Cl2NO2	304.2	C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0V9BD	Bicalutamide	Approved	2375	C18H14F4N2O4S	430.4	CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0VM2L	Zoledronate	Approved	68740	C5H10N2O7P2	272.09	C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0VT8P	Famciclovir	Approved	3324	C14H19N5O4	321.33	CC(=O)OCC(CCN1C=NC2=CN=C(N=C21)N)COC(=O)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0W0BF	Anastrozole	Approved	2187	C17H19N5	293.4	CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0W9LX	Carvedilol	Approved	2585	C24H26N2O4	406.5	COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0WI3T	Saquinavir	Approved	441243	C38H50N6O5	670.8	CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@H]([C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0WN0U	Felodipine	Approved	3333	C18H19Cl2NO4	384.2	CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0WS1X	Cefdinir	Approved	6915944	C14H13N5O5S2	395.4	C=CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\\O)/C3=CSC(=N3)N)SC1)C(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0X0RI	Mexiletine	Approved	4178	C11H17NO	179.26	CC1=C(C(=CC=C1)C)OCC(C)N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0X4RN	Lidocaine	Approved	3676	C14H22N2O	234.34	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0X5SD	Disulfiram	Approved	3117	C10H20N2S4	296.5	CCN(CC)C(=S)SSC(=S)N(CC)CC	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0X5XU	Decitabine	Approved	451668	C8H12N4O4	228.21	C1[C@@H]([C@H](O[C@H]1N2C=NC(=NC2=O)N)CO)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0X6GN	Loteprednol Etabonate	Approved	444025	C24H31ClO7	466.9	CCOC(=O)O[C@@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)C=C[C@]34C)O)C)C(=O)OCCl	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0X7DE	Nefazodone	Approved	4449	C25H32ClN5O2	470	CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0X7XG	Fusidic Acid	Approved	3000226	C31H48O6	516.7	C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]\\4[C@@]3(C[C@@H](/C4=C(/CCC=C(C)C)\\C(=O)O)OC(=O)C)C)O)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0X9RG	Butorphanol	Approved	5361092	C21H29NO2	327.5	C1CC[C@]2([C@H]3CC4=C([C@]2(C1)CCN3CC5CCC5)C=C(C=C4)O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0X9ZC	Cefadroxil	Approved	47965	C16H17N3O5S	363.4	CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)[C@@H](C3=CC=C(C=C3)O)N)SC1)C(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0XF8W	Pyrazinamide	Approved	1046	C5H5N3O	123.11	C1=CN=C(C=N1)C(=O)N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0Y0SW	Flutamide	Approved	3397	C11H11F3N2O3	276.21	CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0Y2CJ	Minoxidil	Approved	4201	C9H15N5O	209.25	C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0Y3MO	Amikacin	Approved	37768	C22H43N5O13	585.6	C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1NC(=O)[C@H](CCN)O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CN)O)O)O)N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0Y5UG	Amitriptyline	Approved	2160	C20H23N	277.4	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0Y7EM	Felbinac	Approved	3332	C14H12O2	212.24	C1=CC=C(C=C1)C2=CC=C(C=C2)CC(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0Y7IU	Budesonide	Approved	5281004	C25H34O6	430.5	CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@@]5([C@H]4[C@H](C[C@@]3([C@@]2(O1)C(=O)CO)C)O)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0Y7ZU	Dacarbazine	Approved	135398738	C6H10N6O	182.18	.	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0Y9LL	Lorcainide	Approved	42884	C22H27ClN2O	370.9	CC(C)N1CCC(CC1)N(C2=CC=C(C=C2)Cl)C(=O)CC3=CC=CC=C3	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0Z1RV	Clozapine	Approved	135398737	C18H19ClN4	326.8	.	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0Z4EI	Mifepristone	Approved	55245	C29H35NO2	429.6	CC#C[C@@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)C5=CC=C(C=C5)N(C)C)C)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0Z4SB	Glipizide	Approved	3478	C21H27N5O4S	445.5	CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0Z4UN	Pimecrolimus	Approved	6509979	C43H68ClNO11	810.4	CC[C@@H]1/C=C(/C[C@@H](C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC1=O)O)C)/C(=C/[C@@H]4CC[C@@H]([C@@H](C4)OC)Cl)/C)O)C)OC)OC)C)\\C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0Z6UC	Sumatriptan	Approved	5358	C14H21N3O2S	295.4	CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0Z8EX	Stavudine	Approved	18283	C10H12N2O4	224.21	CC1=CN(C(=O)NC1=O)[C@H]2C=C[C@H](O2)CO	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0Z9QR	Zalcitabine	Approved	24066	C9H13N3O3	211.22	C1C[C@@H](O[C@@H]1CO)N2C=CC(=NC2=O)N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0ZB7K	Zopiclone	Approved	5735	C17H17ClN6O3	388.8	CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0ZS8P	Clomipramine	Approved	2801	C19H23ClN2	314.9	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0ZU9R	Ritonavir	Approved	392622	C37H48N6O5S2	720.9	CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CC=CC=C2)C[C@@H]([C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0D8XY	ATOSIBAN	Phase 4	5311010	C43H67N11O12S2	994.2	CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSCCC(=O)N[C@@H](C(=O)N1)CC2=CC=C(C=C2)OCC)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN)C(=O)NCC(=O)N)CC(=O)N)[C@@H](C)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0N1FS	Diacerein	Phase 4	26248	C19H12O8	368.3	CC(=O)OC1=CC=CC2=C1C(=O)C3=C(C2=O)C=C(C=C3OC(=O)C)C(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D00TIG	RG3806	Preregistration	6917964	C51H70N10O12S2	1079.3	C[C@H]([C@H]1C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)[C@@H](CC5=CC=CC=C5)N)C(=O)N[C@H](CO)[C@@H](C)O)O.CC(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D07WCB	Colchicine	Phase 3	6167	C22H25NO6	399.4	CC(=O)N[C@H]1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D09YDM	Camptothecin	Phase 3	24360	C20H16N2O4	348.4	CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=CC5=CC=CC=C5N=C4C3=C2)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0DV8K	Dexamethasone	Phase 3	5743	C22H29FO5	392.5	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0E2RD	Abraxane	Phase 3	36314	C47H51NO14	853.9	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0E6FS	Rivaroxaban	Phase 3	9875401	C19H18ClN3O5S	435.9	C1COCC(=O)N1C2=CC=C(C=C2)N3C[C@@H](OC3=O)CNC(=O)C4=CC=C(S4)Cl	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0EO8K	Valsartan	Phase 3	60846	C24H29N5O3	435.5	CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)[C@@H](C(C)C)C(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0F7XT	Fluoxetine	Phase 3	3386	C17H18F3NO	309.33	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0HC8Q	PN-200	Phase 3	3784	C19H21N3O5	371.4	CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0J7KR	Lenalidomide	Phase 3	216326	C13H13N3O3	259.26	C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0Q9CY	HKI-272	Phase 3	9915743	C30H29ClN6O3	557	CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)/C=C/CN(C)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0Y1FO	Rubitecan	Phase 3	472335	C20H15N3O6	393.3	CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC=C5[N+](=O)[O-])N=C4C3=C2)O	IC50 = 60500 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0G6XU	Melatonin	Phase 2/3	896	C13H16N2O2	232.28	CC(=O)NCCC1=CNC2=C1C=C(C=C2)OC	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D04XYL	2'3'-Dideoxyinosine	Phase 2	135398739	C10H12N4O3	236.23	.	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0DL8A	Clarithromycin	Phase 2	84029	C38H69NO13	748	CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)O)(C)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0E3TC	Staurosporine	Phase 2	44259	C28H26N4O3	466.5	C[C@@]12[C@@H]([C@@H](C[C@@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)NC)OC	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0ED3R	Clopidogrel	Phase 2	60606	C16H16ClNO2S	321.8	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0S4SX	K-134	Phase 2	130313	C8H11NO5S	233.24	CC1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)O)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0SD9V	Flupirtine	Phase 2	53276	C15H17FN4O2	304.32	CCOC(=O)NC1=C(N=C(C=C1)NCC2=CC=C(C=C2)F)N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0VG0D	BEZ235	Phase 2	11977753	C30H23N5O	469.5	CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0TO2R	Fludarabine phosphate	Phase 1	30751	C10H13FN5O7P	365.21	C1=NC2=C(N=C(N=C2N1[C@H]3[C@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O)F)N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D01RYO	Gefitinib	Patented	123631	C22H24ClFN4O3	446.9	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D03XTA	PMID28870136-Compound-49	Patented	4740	C13H18N4O3	278.31	CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D08VAT	Undecylenic acid derivative 1	Patented	5634	C11H20O2	184.27	C=CCCCCCCCCC(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0DF2M	PMID28870136-Compound-48	Patented	2153	C7H8N4O2	180.16	CN1C2=C(C(=O)N(C1=O)C)NC=N2	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0E2AD	PMID27336223-Compound-10	Patented	5381	C21H21NO2S	351.5	CCOC(=O)C1=CN=C(C=C1)C#CC2=CC3=C(C=C2)SCCC3(C)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0H9IX	PMID28870136-Compound-52	Patented	2519	C8H10N4O2	194.19	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0KP0U	PMID26394986-Compound-22	Patented	2662	C17H14F3N3O2S	381.4	CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0R6LF	Citalopram derivative 1	Patented	2771	C20H21FN2O	324.4	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0W8JK	PMID27336223-Compound-11	Patented	60164	C28H28O3	412.5	COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0Y3DN	Flavonoid derivative 4	Patented	5280343	C15H10O7	302.23	C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D01PIL	Remoxipride	Withdrawn from market	54477	C16H23BrN2O3	371.27	CCN1CCC[C@H]1CNC(=O)C2=C(C=CC(=C2OC)Br)OC	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D01VAB	Alprenolol	Withdrawn from market	2119	C15H23NO2	249.35	CC(C)NCC(COC1=CC=CC=C1CC=C)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D02LHR	INDORAMIN	Withdrawn from market	33625	C22H25N3O	347.5	C1CN(CCC1NC(=O)C2=CC=CC=C2)CCC3=CNC4=CC=CC=C43	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D03JPH	Isoxicam	Withdrawn from market	54677972	C14H13N3O5S	335.34	CC1=CC(=NO1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D05RUM	Melperone	Withdrawn from market	15387	C16H22FNO	263.35	CC1CCN(CC1)CCCC(=O)C2=CC=C(C=C2)F	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D06ABW	CLIOQUINOL	Withdrawn from market	2788	C9H5ClINO	305.5	C1=CC2=C(C(=C(C=C2Cl)I)O)N=C1	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D07XPE	Phenformin	Withdrawn from market	8249	C10H15N5	205.26	C1=CC=C(C=C1)CCN=C(N)N=C(N)N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D08SOF	Terfenadine	Withdrawn from market	5405	C32H41NO2	471.7	CC(C)(C)C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0C0JT	Nimesulide	Withdrawn from market	4495	C13H12N2O5S	308.31	CS(=O)(=O)NC1=C(C=C(C=C1)[N+](=O)[O-])OC2=CC=CC=C2	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0O2IE	Phenacetin	Withdrawn from market	4754	C10H13NO2	179.22	CCOC1=CC=C(C=C1)NC(=O)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0OS6O	Sertindole	Withdrawn from market	60149	C24H26ClFN4O	440.9	C1CN(CCC1C2=CN(C3=C2C=C(C=C3)Cl)C4=CC=C(C=C4)F)CCN5CCNC5=O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0Y2HR	Astemizole	Withdrawn from market	2247	C28H31FN4O	458.6	COC1=CC=C(C=C1)CCN2CCC(CC2)NC3=NC4=CC=CC=C4N3CC5=CC=C(C=C5)F	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0Y4FL	Roxithromycin	Withdrawn from market	6915744	C41H76N2O15	837	CC[C@@H]1[C@@]([C@@H]([C@H](/C(=N/OCOCCOC)/[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0Y8UB	Agomelatine	Withdrawn from market	82148	C15H17NO2	243.3	CC(=O)NCCC1=CC=CC2=C1C=C(C=C2)OC	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D04BQR	Acecainide	Discontinued in Phase 3	4342	C15H23N3O2	277.36	CCN(CC)CCNC(=O)C1=CC=C(C=C1)NC(=O)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0S6QR	BMS-204352	Discontinued in Phase 3	214350	C16H10ClF4NO2	359.7	COC1=C(C=C(C=C1)Cl)[C@]2(C3=C(C=C(C=C3)C(F)(F)F)NC2=O)F	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0G9ZW	Roquinimex	Discontinued in Phase 1	54676478	C18H16N2O3	308.3	CN1C2=CC=CC=C2C(=C(C1=O)C(=O)N(C)C3=CC=CC=C3)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0J9GD	Mevastatin	Terminated	64715	C23H34O5	390.5	CC[C@H](C)C(=O)O[C@H]1CCC=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B02PGF	Tyverb	Investigative	11679357	C36H34ClFN4O7S2	753.3	CC1=CC=C(C=C1)S(=O)(=O)O.CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B04GRD	Rasagiline mesylate	Investigative	3052775	C13H17NO3S	267.35	CS(=O)(=O)O.C#CCN[C@@H]1CCC2=CC=CC=C12	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B0F6DY	CID 137648451	Investigative	137648451	C206H305N51O66	4552	CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC5=CNC6=CC=CC=C65)C(=O)N[C@@H](CC7=CC=CC=C7)C(=O)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC8=CN=CN8)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC9=CC=C(C=C9)O)NC(=O)C.CC(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B0G8QV	(3S,6S,9S,12R,15S,18S,21S,24S,27R,30S,33S)-30-Ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-24-[(2S)-1-[4-(2-methoxyethyl)piperazin-1-yl]propan-2-yl]-1,4,7,10,12,15,19,25,27,28-decamethyl-6,9,18-tris(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone	Investigative	90142631	C69H125N13O13	1344.8	CC[C@H]1C(=O)N([C@@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)[C@@H](C)CN2CCN(CC2)CCOC)C)C)C	IC50 = 140000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B0NO2H	Sutent	Investigative	44181971	C26H33FN4O7	532.6	CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C.C(C(C(=O)O)O)C(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B0QLV8	Medroxyprogesterone acetate	Investigative	6279	C24H34O4	386.5	C[C@H]1C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)OC(=O)C)C)[C@@]4(C1=CC(=O)CC4)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B0VJ9Q	Pazopanib	Investigative	10113978	C21H23N7O2S	437.5	CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B17AOW	CID 11996283	Investigative	11996283	C22H29Cl2N5O7S	578.5	CC1=C(C(=C(N1)C(=O)N[C@@H]2CCN(C[C@@H]2OC)C3=NC(=C(S3)C(=O)O)C(=O)NC(COC)COC)Cl)Cl	IC50 = 200000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B18HYR	Pindolol	Investigative	4828	C14H20N2O2	248.32	CC(C)NCC(COC1=CC=CC2=C1C=CN2)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B18QDH	Seroquel	Investigative	5281025	C46H54N6O8S2	883.1	C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42.C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42.C(=C/C(=O)O)\\C(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B1CSH5	Spiramycin	Investigative	5289394	C43H74N2O14	843.1	C[C@@H]1C/C=C/C=C/[C@@H]([C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)O)OC)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)O)N(C)C)O)CC=O)C)O[C@H]4CC[C@@H]([C@H](O4)C)N(C)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B1IL2S	Miconazole nitrate	Investigative	68553	C18H15Cl4N3O4	479.1	C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl.[N+](=O)(O)[O-]	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B1JAC2	Bisoprolol fumarate	Investigative	6917733	C22H35NO8	441.5	CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O.C(=C/C(=O)O)\\C(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B1O0UE	2-(6-Hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid	Investigative	3383	C20H12O5	332.3	C1=CC=C(C(=C1)C2=C3C=CC(=O)C=C3OC4=C2C=CC(=C4)O)C(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B1SMF4	Perindopril erbumine	Investigative	441313	C23H43N3O5	441.6	CCC[C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)O.CC(C)(C)N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B1SY2R	Oxytocin acetate	Investigative	12004215	C45H70N12O14S2	1067.2	CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N.CC(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B1ZKU4	Latanoprost	Investigative	5311221	C26H40O5	432.6	CC(C)OC(=O)CCC/C=C\\C[C@H]1[C@H](C[C@H]([C@@H]1CC[C@H](CCC2=CC=CC=C2)O)O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B21KSJ	Guanfacine	Investigative	3519	C9H9Cl2N3O	246.09	C1=CC(=C(C(=C1)Cl)CC(=O)N=C(N)N)Cl	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B28MJC	(E)-But-2-enedioic acid;N-[2-hydroxy-5-[1-hydroxy-2-[1-(4-methoxyphenyl)propan-2-ylamino]ethyl]phenyl]formamide	Investigative	9912089	C23H28N2O8	460.5	CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O.C(=C/C(=O)O)\\C(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B2DP6E	L-Hyoscyamine	Investigative	3661; 6321299	C17H23NO3	289.4	CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B2SA1B	Minovlar	Investigative	9839243	C20H26O2	298.4	C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@]2(C#C)O)CCC4=CC(=O)CC[C@H]34	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B2SJC8	[(1S,2S)-2-[2-[3-(1H-Benzimidazol-2-yl)propyl-methylamino]ethyl]-6-fluoro-1-propan-2-yl-3,4-dihydro-1H-naphthalen-2-yl] 2-methoxyacetate;hydrochloride	Investigative	23623618	C29H39ClFN3O3	532.1	CC(C)[C@H]1C2=C(CC[C@@]1(CCN(C)CCCC3=NC4=CC=CC=C4N3)OC(=O)COC)C=C(C=C2)F.Cl	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B2ZW3Q	Natamycin	Investigative	5284447	C33H47NO13	665.7	C[C@@H]1C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@@H]3[C@H](O3)/C=C/C(=O)O1)O)O)O)C(=O)O)O[C@H]4[C@H]([C@H]([C@@H]([C@H](O4)C)O)N)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B32SAP	Carbon tetrachloride	Investigative	5943	CCl4	153.8	C(Cl)(Cl)(Cl)Cl	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B39XAJ	Pemirolast potassium	Investigative	443866	C10H7KN6O	266.3	CC1=CC=CN2C1=NC=C(C2=O)C3=NN=N[N-]3.[K+]	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B3KVX7	Bupivacaine hydrochloride	Investigative	64737	C18H29ClN2O	324.9	CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C.Cl	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B3PX2N	Idazoxan	Investigative	54459	C11H12N2O2	204.22	C1CN=C(N1)C2COC3=CC=CC=C3O2	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B40ZAP	(1S,2R,13R,14S,17S,18S)-17-Ethynyl-2,18-dimethyl-7-oxa-6-azapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-ol	Investigative	11416460	C22H27NO2	337.5	C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@]2(C#C)O)CCC4=CC5=C(C[C@]34C)C=NO5	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B47WJP	Metocurine	Investigative	21233	C40H48N2O6+2	652.8	C[N+]1(CCC2=CC(=C3C=C2[C@@H]1CC4=CC=C(C=C4)OC5=C6[C@@H](CC7=CC(=C(C=C7)OC)O3)[N+](CCC6=CC(=C5OC)OC)(C)C)OC)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B4CHM1	Terlipressin acetate	Investigative	72734347	C54H78N16O17S2	1287.4	CC(=O)O.C1C[C@H](N(C1)C(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)NC(=O)CNC(=O)CNC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B4KT7N	Aquex	Investigative	2804	C14H20ClN3O3S	345.8	CC1CCCC(N1NC(=O)C2=CC(=C(C=C2)Cl)S(=O)(=O)N)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B4T0WK	Enalapril maleate	Investigative	5388961	C24H32N2O9	492.5	CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O.C(=C\\C(=O)O)\\C(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B4UTY5	Ebastine	Investigative	3191	C32H39NO2	469.7	CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN2CCC(CC2)OC(C3=CC=CC=C3)C4=CC=CC=C4	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B4Y5QZ	Chembl4288001	Investigative	145990715	C21H19ClO5	386.8	CC#C[C@@H](CC(=O)O)C1=CC=C(C=C1)OC[C@H]2COC3=C(O2)C=C(C=C3)Cl	IC50 ~ 100000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B4YJK1	Gemcitabine hydrochloride	Investigative	60749	C9H12ClF2N3O4	299.66	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F.Cl	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B51RBF	Ergocalciferol	Investigative	5280793	C28H44O	396.6	C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B57LPK	Ertapenem sodium	Investigative	23674512	C22H24N3NaO7S	497.5	C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)C(=O)NC4=CC=CC(=C4)C(=O)[O-])C(=O)O)[C@@H](C)O.[Na+]	IC50 = 56200 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B5GN7B	Somatostatin	Investigative	16129706	C76H104N18O19S2	1637.9	C[C@H]([C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)CC5=CC=CC=C5)CC(=O)N)CCCCN)NC(=O)CNC(=O)[C@H](C)N)C(=O)O)CO)[C@@H](C)O)CC6=CC=CC=C6)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B5I4XW	Ketorolac tromethamine	Investigative	84003	C19H24N2O6	376.4	C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O.C(C(CO)(CO)N)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B5KY9W	Cefotaxime sodium	Investigative	10695961	C16H16N5NaO7S2	477.5	CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\\OC)/C3=CSC(=N3)N)SC1)C(=O)[O-].[Na+]	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B5ORA4	Bromopride	Investigative	2446	C14H22BrN3O2	344.25	CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Br	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B5PKM1	Procarbazine hydrochloride	Investigative	9703	C12H20ClN3O	257.76	CC(C)NC(=O)C1=CC=C(C=C1)CNNC.Cl	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B5XS6Y	Goserelin acetate	Investigative	16052011	C61H88N18O16	1329.5	CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NNC(=O)N)NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)NC(=O)[C@H](CC5=CN=CN5)NC(=O)[C@@H]6CCC(=O)N6.CC(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B5ZAR0	Racecadotril	Investigative	107751	C21H23NO4S	385.5	CC(=O)SCC(CC1=CC=CC=C1)C(=O)NCC(=O)OCC2=CC=CC=C2	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B65WUT	Betamipron	Investigative	71651	C10H11NO3	193.2	C1=CC=C(C=C1)C(=O)NCCC(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B6U8ZR	Vincristine sulfate	Investigative	249332	C46H58N4O14S	923	CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O.OS(=O)(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B6ULF0	Etoposide phosphate	Investigative	6918092	C29H33O16P	668.5	C[C@@H]1OC[C@@H]2[C@@H](O1)[C@@H]([C@H]([C@@H](O2)O[C@H]3[C@H]4COC(=O)[C@@H]4[C@@H](C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)OP(=O)(O)O)OC)O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B6UW7J	Ceftin	Investigative	6321416	C20H22N4O10S	510.5	CC(OC(=O)C)OC(=O)C1=C(CS[C@H]2N1C(=O)[C@H]2NC(=O)/C(=N\\OC)/C3=CC=CO3)COC(=O)N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B6Z5SC	Eflornithine hydrochloride	Investigative	57004	C6H13ClF2N2O2	218.63	C(CC(C(F)F)(C(=O)O)N)CN.Cl	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B70EHX	Norethisterone acetate	Investigative	63021	C22H28O3	340.5	CC(=O)O[C@@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@H]34)C)C#C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B71CUX	Tobramycin	Investigative	36294	C18H37N5O9	467.5	C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CN)O)N)N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B73JUE	Solgol	Investigative	4411	C17H27NO4	309.4	CC(C)(C)NCC(COC1=CC=CC2=C1CC(C(C2)O)O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B7DYV4	Alendronate sodium	Investigative	16760285	C4H12NNaO7P2	271.08	C(CC(O)(P(=O)(O)O)P(=O)(O)[O-])CN.[Na+]	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B7O0WI	Terbinafine hydrochloride	Investigative	5282481	C21H26ClN	327.9	CC(C)(C)C#C/C=C/CN(C)CC1=CC=CC2=CC=CC=C21.Cl	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B7P4CT	CID 11996131	Investigative	11996131	C16H18Cl2N4O4S	433.3	CC1=C(C(=C(N1)C(=O)N[C@@H]2CCN(C[C@@H]2OC)C3=NC=C(S3)C(=O)O)Cl)Cl	EC50 = 71000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B7QKL0	GDC-0941 dimethanesulfonate	Investigative	56972143	C25H35N7O9S4	705.9	CS(=O)(=O)N1CCN(CC1)CC2=CC3=C(S2)C(=NC(=N3)C4=C5C=NNC5=CC=C4)N6CCOCC6.CS(=O)(=O)O.CS(=O)(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B7S0CH	Bupropion hydrochloride	Investigative	62884	C13H19Cl2NO	276.2	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C.Cl	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B7UV2C	Pravastatin sodium	Investigative	16759173	C23H35NaO7	446.5	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)[O-])O)O)O.[Na+]	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B80GPO	Posaconazole	Investigative	468595	C37H42F2N8O4	700.8	CC[C@@H]([C@H](C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OC[C@H]5C[C@](OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B82SIA	Sporanox	Investigative	3793	C35H38Cl2N8O4	705.6	CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B84VPC	Dimenhydrinate	Investigative	10660	C24H28ClN5O3	470	CN1C2=C(C(=O)N(C1=O)C)NC(=N2)Cl.CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B85DNT	Methyldopa hydrate	Investigative	18530292	C10H15NO5	229.23	C[C@](CC1=CC(=C(C=C1)O)O)(C(=O)O)N.O	IC50 = 64200 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B8OI4L	Oxiconazole nitrate	Investigative	9556529	C18H14Cl4N4O4	492.1	C1=CC(=C(C=C1Cl)Cl)CO/N=C(\\CN2C=CN=C2)/C3=C(C=C(C=C3)Cl)Cl.[N+](=O)(O)[O-]	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B8UC2V	Sulfacetamide sodium	Investigative	4022878	C8H9N2NaO3S	236.23	CC(=O)[N-]S(=O)(=O)C1=CC=C(C=C1)N.[Na+]	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B8UM1P	Doxazosin mesylate	Investigative	62978	C24H29N5O8S	547.6	COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC.CS(=O)(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B93NQT	(1R,2R,3R,6R,7S,9R,10R,12R,13S,15R,17S)-9-[(2S,3R,4S,6R)-4-(Dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-ethyl-2,10-dihydroxy-7-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-15-(2-methoxyethoxymethyl)-2,6,10,12,17-pentamethyl-4,16-dioxa-14-azabicyclo[11.3.1]heptadecan-5-one	Investigative	137654606	C41H76N2O14	821	CC[C@@H]1[C@@]([C@H]2[C@H]([C@H]([C@@H](C[C@@]([C@@H](C[C@@H]([C@H](C(=O)O1)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)OC)O[C@H]4[C@@H]([C@H](C[C@H](O4)C)N(C)C)O)(C)O)C)N[C@H](O2)COCCOC)C)(C)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B9L5CZ	Ranitidine Base	Investigative	5039	C13H22N4O3S	314.41	CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B9P2MZ	Pancuronium bromide	Investigative	27350	C35H60Br2N2O4	732.7	CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@@H]([C@]2(C[C@@H]1[N+]4(CCCCC4)C)C)CC[C@]5([C@H]3C[C@@H]([C@@H]5OC(=O)C)[N+]6(CCCCC6)C)C.[Br-].[Br-]	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	B9WG1K	(3S,6S,9R,10R,11S,12S,13E,15E,18S)-18-((2E,4E)-6-(1,2-Oxazinan-2-yl)-6-oxohexa-2,4-dien-2-yl)-3-(3-fluoro-5-hydroxybenzyl)-10,12-dihydroxy-6-isopropyl-11-methyl-9-(3-oxobutyl)-19-oxa-1,4,7,25-tetraazabicyclo[19.3.1]pentacosa-13,15-diene-2,5,8,20-tetraone	Investigative	60203940	C45H62FN5O11	868	C[C@H]1[C@H](/C=C/C=C/C[C@H](OC(=O)C2CCCN(N2)C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]([C@@H]1O)CCC(=O)C)C(C)C)CC3=CC(=CC(=C3)F)O)/C(=C/C=C/C(=O)N4CCCCO4)/C)O	IC50 ~ 50000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BA0OE1	Scopolamine hydrobromide trihydrate	Investigative	20055509	C17H28BrNO7	438.3	CN1[C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)[C@H](CO)C4=CC=CC=C4.O.O.O.Br	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BABV29	Triamcinolone acetonide	Investigative	6436	C24H31FO6	434.5	C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@@H]4[C@]2(OC(O4)(C)C)C(=O)CO)CCC5=CC(=O)C=C[C@@]53C)F)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BAQ89X	Doxepin	Investigative	3158	C19H21NO	279.4	CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BAR85X	Leuprolide acetate	Investigative	657180	C61H88N16O14	1269.4	CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)NC(=O)[C@H](CC5=CN=CN5)NC(=O)[C@@H]6CCC(=O)N6.CC(=O)O	IC50 = 80200 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BB49LU	Atracurium besylate	Investigative	47320	C65H82N2O18S2	1243.5	C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-]	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BB6L0X	Eptifibatide (acetate)	Investigative	12001375	C37H53N11O11S2	892	CC(=O)O.C1C[C@H]2C(=O)N[C@@H](CSSCCC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N2C1)CC3=CNC4=CC=CC=C43)CC(=O)O)CCCCN=C(N)N)C(=O)N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BBT6Y9	Oxacillin sodium	Investigative	23667631	C19H18N3NaO5S	423.4	CC1=C(C(=NO1)C2=CC=CC=C2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)[O-].[Na+]	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BBX29G	Aminophylline	Investigative	9433	C16H24N10O4	420.43	CN1C2=C(C(=O)N(C1=O)C)NC=N2.CN1C2=C(C(=O)N(C1=O)C)NC=N2.C(CN)N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BC0DF5	N,N-Dimethyl-2-(6-methyl-2-(p-tolyl)imidazo[1,2-a]pyridin-3-yl)acetamide 2,3-dihydroxysuccinate	Investigative	18004026	C23H27N3O7	457.5	CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C.C(C(C(=O)O)O)(C(=O)O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BCG41B	Unii-frh0WC636A	Investigative	11996857	C21H18O12	462.4	C1=CC(=CC=C1C2=CC(=O)C3=C(O2)C=C(C(=C3O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)O)O)O)O)O)O	IC50 = 50000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BD3IP0	Cibenzoline	Investigative	2747	C18H18N2	262.3	C1CN=C(N1)C2CC2(C3=CC=CC=C3)C4=CC=CC=C4	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BD5AK1	Sodium;(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-5,6-dioxo-1H-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	Investigative	16051965	C18H18N8NaO7S3+	577.6	CN1C(=NC(=O)C(=O)N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\\OC)/C4=CSC(=N4)N)SC2)C(=O)O.[Na+]	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BD9XY0	Estrumate	Investigative	23716436	C22H28ClNaO6	446.9	C1C(C(C(C1O)/C=C/C(COC2=CC(=CC=C2)Cl)O)C/C=C\\CCCC(=O)[O-])O.[Na+]	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BDO6H9	Artesunate	Investigative	6917864	C19H28O8	384.4	C[C@@H]1CC[C@H]2[C@H]([C@@H](O[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)OC(=O)CCC(=O)O)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BDU1M3	Anthralin	Investigative	2202	C14H10O3	226.23	C1C2=C(C(=CC=C2)O)C(=O)C3=C1C=CC=C3O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BDVT80	Strontium ranelate	Investigative	6918182	C12H6N2O8SSr2	513.5	C(C1=C(SC(=C1C#N)N(CC(=O)[O-])CC(=O)[O-])C(=O)[O-])C(=O)[O-].[Sr+2].[Sr+2]	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BDY51S	Piperacillin sodium	Investigative	23666879	C23H26N5NaO7S	539.5	CCN1CCN(C(=O)C1=O)C(=O)N[C@H](C2=CC=CC=C2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)[O-].[Na+]	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BESW08	1-Naphthyl isothiocyanate	Investigative	11080	C11H7NS	185.25	C1=CC=C2C(=C1)C=CC=C2N=C=S	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BEU30C	Epirubicin hydrochloride	Investigative	65348	C27H30ClNO11	580	C[C@H]1[C@@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O.Cl	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BEY3H8	Kanamycin	Investigative	6032	C18H36N4O11	484.5	C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)N)O)N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BF6A3D	Bronopol	Investigative	2450	C3H6BrNO4	199.99	C(C(CO)([N+](=O)[O-])Br)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BF7Y2T	Valrubicin	Investigative	454216	C34H36F3NO13	723.6	CCCCC(=O)OCC(=O)[C@]1(C[C@@H](C2=C(C1)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4OC)O)O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O)NC(=O)C(F)(F)F)O	IC50 = 64000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BG25CF	Ticlopidine hydrochloride	Investigative	65335	C14H15Cl2NS	300.2	C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl.Cl	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BG3PY9	Ketotifen fumarate	Investigative	5282408	C23H23NO5S	425.5	CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1.C(=C/C(=O)O)\\C(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BG52JP	CID 25223515	Investigative	25223515	C19H21Cl2N7O4S	514.4	CC1=C(C(=C(N1)C(=O)N[C@@H]2CCN(C[C@@H]2OC)C3=NC(=C(S3)C(=O)O)C4=NC=NN4C)Cl)Cl	EC50 = 140000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BGC4L3	Baclofen	Investigative	2284	C10H12ClNO2	213.66	C1=CC(=CC=C1C(CC(=O)O)CN)Cl	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BGX14H	Valinomycin	Investigative	3000706	C54H90N6O18	1111.3	C[C@H]1C(=O)N[C@H](C(=O)O[C@@H](C(=O)N[C@@H](C(=O)O[C@H](C(=O)N[C@H](C(=O)O[C@@H](C(=O)N[C@@H](C(=O)O[C@H](C(=O)N[C@H](C(=O)O[C@@H](C(=O)N[C@@H](C(=O)O1)C(C)C)C(C)C)C(C)C)C)C(C)C)C(C)C)C(C)C)C)C(C)C)C(C)C)C(C)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BH1WY8	Prolixin	Investigative	6602611	C22H27ClF3N3OS	474	C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO.Cl	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BH97ZT	Cetrorelix acetate	Investigative	25078429	C72H96ClN17O16	1491.1	C[C@H](C(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CCCNC(=O)N)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@@H](CC3=CN=CC=C3)NC(=O)[C@@H](CC4=CC=C(C=C4)Cl)NC(=O)[C@@H](CC5=CC6=CC=CC=C6C=C5)NC(=O)C.CC(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BHLU51	Ethambutol dihydrochloride	Investigative	14051	C10H26Cl2N2O2	277.23	CC[C@@H](CO)NCCN[C@@H](CC)CO.Cl.Cl	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BHP1U8	Azlocillin sodium	Investigative	23685176	C20H22N5NaO6S	483.5	CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)NC(=O)N4CCNC4=O)C(=O)[O-])C.[Na+]	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BHW6D1	Dolasetron mesylate	Investigative	3033817	C20H24N2O6S	420.5	CS(=O)(=O)O.C1[C@@H]2CC(C[C@H]3N2CC(=O)C1C3)OC(=O)C4=CNC5=CC=CC=C54	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BI1XC3	Propranolol	Investigative	4946	C16H21NO2	259.339	CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BI83SP	Flunisolide	Investigative	82153	C24H31FO6	434.5	C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1C[C@@H]4[C@]2(OC(O4)(C)C)C(=O)CO)C[C@@H](C5=CC(=O)C=C[C@]35C)F)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BI8WN9	Duloxetine hydrochloride	Investigative	60834	C18H20ClNOS	333.9	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32.Cl	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BIQE35	Sildenafil citrate	Investigative	135413523	C28H38N6O11S	666.7	CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C.C(C(=O)O)C(CC(=O)O)(C(=O)O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BIRP38	Rizatriptan benzoate	Investigative	77997	C22H25N5O2	391.5	CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3.C1=CC=C(C=C1)C(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BJ2V4U	Nefopam	Investigative	4450	C17H19NO	253.34	CN1CCOC(C2=CC=CC=C2C1)C3=CC=CC=C3	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BJ4HI8	Tilorone	Investigative	5475	C25H34N2O3	410.5	CCN(CC)CCOC1=CC2=C(C=C1)C3=C(C2=O)C=C(C=C3)OCCN(CC)CC	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BK4A1T	Tolterodine tartrate	Investigative	9847786	C26H37NO7	475.6	CC1=CC(=C(C=C1)O)[C@H](CCN(C(C)C)C(C)C)C2=CC=CC=C2.C(C(C(=O)O)O)(C(=O)O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BK4DN9	Fluticasone propionate	Investigative	444036	C25H31F3O5S	500.6	CCC(=O)O[C@@]1([C@@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2C[C@@H](C4=CC(=O)C=C[C@@]43C)F)F)O)C)C)C(=O)SCF	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BK4JY5	N-(5-((4-(2-(6,7-Dimethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl)phenyl)aminocarbonyl)-2-methylphenyl)quinoline-3-carboxamide	Investigative	25223106	C37H36N4O4	600.7	CC1=C(C=C(C=C1)C(=O)NC2=CC=C(C=C2)CCN3CCC4=CC(=C(C=C4C3)OC)OC)NC(=O)C5=CC6=CC=CC=C6N=C5	IC50 ~ 50000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BK87HA	(11R,16S)-Misoprostol	Investigative	9886273	C22H38O5	382.5	CCCC[C@@](C)(C/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1CCCCCCC(=O)OC)O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BKC4E6	Oseltamivir phosphate	Investigative	78000	C16H31N2O8P	410.4	CCC(CC)O[C@@H]1C=C(C[C@@H]([C@H]1NC(=O)C)N)C(=O)OCC.OP(=O)(O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BKG38V	Rocuronium bromide	Investigative	441351	C32H53BrN2O4	609.7	CC(=O)O[C@H]1[C@H](C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(C[C@@H]([C@H](C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C.[Br-]	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BKH3A8	Minocycline hydrochloride	Investigative	54685925	C23H28ClN3O7	493.9	CN(C)[C@H]1[C@@H]2C[C@@H]3CC4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C.Cl	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BKPI93	Megestrol acetate	Investigative	11683	C24H32O4	384.5	CC1=C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)OC(=O)C)C)[C@@]4(C1=CC(=O)CC4)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BKUX96	Ziprasidone mesylate	Investigative	154068	C22H25ClN4O4S2	509	CS(=O)(=O)O.C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BL4H9B	Quinidine	Investigative	441074	C20H24N2O2	324.4	COC1=CC2=C(C=CN=C2C=C1)[C@@H]([C@H]3C[C@@H]4CCN3C[C@@H]4C=C)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BL84ZA	Vecuronium bromide	Investigative	39764	C34H57BrN2O4	637.7	CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@@H]([C@]2(C[C@@H]1N4CCCCC4)C)CC[C@]5([C@H]3C[C@@H]([C@@H]5OC(=O)C)[N+]6(CCCCC6)C)C.[Br-]	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BLH83D	Artemether	Investigative	68911	C16H26O5	298.37	C[C@@H]1CC[C@H]2[C@H]([C@H](O[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)OC)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BM4H6J	Artemisinin	Investigative	68827	C15H22O5	282.33	C[C@@H]1CC[C@H]2[C@H](C(=O)O[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BMI9A4	Cefazolin sodium	Investigative	23675322	C14H13N8NaO4S3	476.5	CC1=NN=C(S1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-].[Na+]	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BMLW83	Atomoxetine hydrochloride	Investigative	54840	C17H22ClNO	291.8	CC1=CC=CC=C1O[C@H](CCNC)C2=CC=CC=C2.Cl	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BMO68C	Verlukast	Investigative	5281888	C26H27ClN2O3S2	515.1	CN(C)C(=O)CCSC(C1=CC=CC(=C1)/C=C/C2=NC3=C(C=CC(=C3)Cl)C=C2)SCCC(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BN18SJ	Pazufloxacin	Investigative	65957	C16H15FN2O4	318.3	C[C@H]1COC2=C3N1C=C(C(=O)C3=CC(=C2C4(CC4)N)F)C(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BN40ZF	Talniflumate	Investigative	48229	C21H13F3N2O4	414.3	C1=CC=C2C(=C1)C(OC2=O)OC(=O)C3=C(N=CC=C3)NC4=CC=CC(=C4)C(F)(F)F	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BN6AT4	Lansoprazole	Investigative	3883	C16H14F3N3O2S	369.4	CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BO08QN	2-(4-{[(3,4-Dichloro-5-methyl-1H-pyrrol-2-yl)carbonyl]amino}piperidin-1-yl)-1,3-thiazole-5-carboxylic acid	Investigative	11463807	C15H16Cl2N4O3S	403.3	CC1=C(C(=C(N1)C(=O)NC2CCN(CC2)C3=NC=C(S3)C(=O)O)Cl)Cl	EC50 = 145000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BO23SL	Ethyl (4R,5S,6S,7R,9R,10R,11E,13E,16R)-6-[(2S,3R,4R,5S,6R)-4-(dimethylamino)-3-hydroxy-5-[(2S,4R,5S,6S)-4-hydroxy-4,6-dimethyl-5-propanoyloxyoxan-2-yl]oxy-6-methyloxan-2-yl]oxy-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-diene-4-carboxylate	Investigative	57393422	C41H67NO15	814	CCC(=O)O[C@H]1[C@@H](O[C@H](C[C@@]1(C)O)O[C@@H]2[C@H](O[C@H]([C@@H]([C@H]2N(C)C)O)O[C@H]3[C@H](C[C@H]([C@H](/C=C/C=C/C[C@H](OC(=O)C[C@H]([C@@H]3OC)C(=O)OCC)C)O)C)CC=O)C)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BO3AY9	Triamcinolone diacetate	Investigative	6216	C25H31FO8	478.5	CC(=O)OCC(=O)[C@]1([C@@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)F)O)C)OC(=O)C)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BP0NC8	Vincaleukoblastine	Investigative	241903	C46H58N4O9	811	CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BPZH19	Loxapine succinate	Investigative	71399	C22H24ClN3O5	445.9	CN1CCN(CC1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl.C(CC(=O)O)C(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BQ0I9V	Nebivolol hydrochloride	Investigative	9933004	C22H26ClF2NO4	441.9	C1CC2=C(C=CC(=C2)F)OC1C(CNCC(C3CCC4=C(O3)C=CC(=C4)F)O)O.Cl	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BQ74DH	Stepronin	Investigative	54120	C10H11NO4S2	273.3	CC(C(=O)NCC(=O)O)SC(=O)C1=CC=CS1	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BQ7P9C	Tegaserod maleate	Investigative	135413539	C20H27N5O5	417.5	CCCCCN=C(N)N/N=C/C1=CNC2=C1C=C(C=C2)OC.C(=C\\C(=O)O)\\C(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BQC4B2	Mafenide acetate	Investigative	25590	C9H14N2O4S	246.29	CC(=O)O.C1=CC(=CC=C1CN)S(=O)(=O)N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BQT3O4	Varenicline tartrate	Investigative	46783232	C17H19N3O6	361.3	C1C2CNCC1C3=CC4=NC=CN=C4C=C23.C(C(C(=O)O)O)(C(=O)O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BQWB80	Iohexol	Investigative	3730	C19H26I3N3O9	821.1	CC(=O)N(CC(CO)O)C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BR46CV	Cefpodoxime proxetil	Investigative	6526396	C21H27N5O9S2	557.6	CC(C)OC(=O)OC(C)OC(=O)C1=C(CS[C@H]2N1C(=O)[C@H]2NC(=O)/C(=N\\OC)/C3=CSC(=N3)N)COC	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BRPV52	Methyl 4-((4-(2-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl)phenyl)aminocarbonyl)-2-(pyrazine-2-carbonylamino)benzoate	Investigative	25223001	C33H33N5O6	595.6	COC1=C(C=C2CN(CCC2=C1)CCC3=CC=C(C=C3)NC(=O)C4=CC(=C(C=C4)C(=O)OC)NC(=O)C5=NC=CN=C5)OC	IC50 ~ 50000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BSC98O	Toremifene citrate	Investigative	3005572	C32H36ClNO8	598.1	CN(C)CCOC1=CC=C(C=C1)/C(=C(/CCCl)\\C2=CC=CC=C2)/C3=CC=CC=C3.C(C(=O)O)C(CC(=O)O)(C(=O)O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BSO5R4	Rosuvastatin calcium	Investigative	5282455	C44H54CaF2N6O12S2	1001.1	CC(C1=NC(=NC(=C1/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-])C2=CC=C(C=C2)F)N(S(=O)(=O)C)C)C.CC(C1=NC(=NC(=C1/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-])C2=CC=C(C=C2)F)N(S(=O)(=O)C)C)C.[Ca+2]	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BT2RC8	Gemifloxacin mesylate	Investigative	9588170	C19H24FN5O7S	485.5	CO/N=C/1\\CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F.CS(=O)(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BT3CA9	Desmopressin acetate	Investigative	9833407	C48H68N14O14S2	1129.3	CC(=O)O.C1C[C@H](N(C1)C(=O)[C@@H]2CSSCCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BT4XH8	Nikethamide	Investigative	5497	C10H14N2O	178.23	CCN(CC)C(=O)C1=CN=CC=C1	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BTK47E	Escitalopram oxalate	Investigative	146571	C22H23FN2O5	414.4	CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F.C(=O)(C(=O)O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BTM19J	Gestodene	Investigative	3033968	C21H26O2	310.4	CC[C@]12CC[C@H]3[C@H]([C@@H]1C=C[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BU06VO	Unii-U6A4H0OY0H	Investigative	5702270	C49H93NO17S	1000.3	CCCCCCCCCCCCOS(=O)(=O)O.CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BU2YQ6	Hydroxychloroquine sulfate	Investigative	12947	C18H28ClN3O5S	434	CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO.OS(=O)(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BU34NM	Clomifene	Investigative	2800	C26H28ClNO	406	CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)Cl)C3=CC=CC=C3	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BU5BC3	Rabeprazole sodium	Investigative	14720269	C18H20N3NaO3S	381.4	CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3[N-]2)OCCCOC.[Na+]	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BU63LY	Scutellarin	Investigative	185617	C21H18O12	462.4	C1=CC(=CC=C1C2=CC(=O)C3=C(C(=C(C=C3O2)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)O)O)O)O)O)O)O	IC50 = 75000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BUC4D6	Chembl4299247	Investigative	145948937	C23H46N6O13	614.6	C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)N)O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O[C@@H]4[C@@H]([C@H]([C@@H](C(O4)CN)O)O)N)O)O)N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BV89ZC	US9090657, Debio-025, 2	Investigative	90070112	C63H113N11O12	1216.6	CCC1C(=O)N(C(C(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)C(C)C)CC)C)C	IC50 ~ 50000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BVC18Y	Warfarin sodium	Investigative	16204922	C19H15NaO4	330.3	CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)[O-].[Na+]	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BVL86Y	Salmeterol xinafoate	Investigative	56801	C36H45NO7	603.7	C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O.C1=CC=C2C(=C1)C=CC(=C2O)C(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BW8Z6M	Chlorpheniramine	Investigative	2725	C16H19ClN2	274.79	CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BWOS92	Dexbrompheniramine maleate	Investigative	6433334	C20H23BrN2O4	435.3	CN(C)CC[C@@H](C1=CC=C(C=C1)Br)C2=CC=CC=N2.C(=C\\C(=O)O)\\C(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BX95BN	Cisapride monohydrate	Investigative	656684	C23H31ClFN3O5	484	COC1CN(CCC1NC(=O)C2=CC(=C(C=C2OC)N)Cl)CCCOC3=CC=C(C=C3)F.O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BXNT61	2-Thenoyltrifluoroacetone	Investigative	5601	C8H5F3O2S	222.19	C1=CSC(=C1)C(=O)CC(=O)C(F)(F)F	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BXSK48	Fesoterodine fumarate	Investigative	9849808	C30H41NO7	527.6	CC(C)C(=O)OC1=C(C=C(C=C1)CO)[C@H](CCN(C(C)C)C(C)C)C2=CC=CC=C2.C(=C/C(=O)O)\\C(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BXU7F5	Moxifloxacin hydrochloride	Investigative	101526	C21H25ClFN3O4	437.9	COC1=C2C(=CC(=C1N3C[C@@H]4CCCN[C@@H]4C3)F)C(=O)C(=CN2C5CC5)C(=O)O.Cl	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BXV8H2	5-Thiazolecarboxylic acid, 2-((3S,4R)-4-(((3,4-dichloro-5-methyl-1H-pyrrol-2-yl)carbonyl)amino)-3-methoxy-1-piperidinyl)-4-((((1S)-2-methoxy-1-methylethyl)amino)carbonyl)-	Investigative	11995990	C21H27Cl2N5O6S	548.4	CC1=C(C(=C(N1)C(=O)N[C@@H]2CCN(C[C@@H]2OC)C3=NC(=C(S3)C(=O)O)C(=O)N[C@@H](C)COC)Cl)Cl	IC50 = 59000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BXZ30V	Feprazone	Investigative	35455	C20H20N2O2	320.4	CC(=CCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BY1Q2I	Tert-Butyl 3-((3S,6S,12aS)-6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino[1',2':1,6]pyrido[3,4-b]indol-3-yl)propanoate	Investigative	10322450	C26H35N3O5	469.6	CC(C)C[C@H]1C2=C(C[C@@H]3N1C(=O)[C@@H](NC3=O)CCC(=O)OC(C)(C)C)C4=C(N2)C=C(C=C4)OC	IC50 ~ 50000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BY92XQ	Ornidazole	Investigative	28061	C7H10ClN3O3	219.62	CC1=NC=C(N1CC(CCl)O)[N+](=O)[O-]	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BY9I8W	Saxagliptin hydrochloride	Investigative	49800073	C18H26ClN3O2	351.9	C1[C@@H]2C[C@@H]2N([C@@H]1C#N)C(=O)[C@H](C34CC5CC(C3)CC(C5)(C4)O)N.Cl	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BYG98Z	Dronedarone hydrochloride	Investigative	219025	C31H45ClN2O5S	593.2	CCCCC1=C(C2=C(O1)C=CC(=C2)NS(=O)(=O)C)C(=O)C3=CC=C(C=C3)OCCCN(CCCC)CCCC.Cl	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BYH7R5	2-((3S,4R)-4-{[(3,4-Dichloro-5-methyl-1H-pyrrol-2-yl)carbonyl]amino}-3-methoxypiperidin-1-yl)-4-{[(2-methoxyethyl)amino]carbonyl}-1,3-thiazole-5-carboxylic acid	Investigative	11995989	C20H25Cl2N5O6S	534.4	CC1=C(C(=C(N1)C(=O)N[C@@H]2CCN(C[C@@H]2OC)C3=NC(=C(S3)C(=O)O)C(=O)NCCOC)Cl)Cl	IC50 = 100000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BZ7ME3	Doxycycline hydrochloride	Investigative	54685920	C22H25ClN2O8	480.9	C[C@@H]1[C@H]2[C@@H]([C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.Cl	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BZ8AT5	Pranoprofen	Investigative	4888	C15H13NO3	255.27	CC(C1=CC2=C(C=C1)OC3=C(C2)C=CC=N3)C(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BZ9E1A	Brompheniramine maleate	Investigative	5281067	C20H23BrN2O4	435.3	CN(C)CCC(C1=CC=C(C=C1)Br)C2=CC=CC=N2.C(=C\\C(=O)O)\\C(=O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BZD25O	Fenoldopam mesylate	Investigative	49659	C17H20ClNO6S	401.9	CS(=O)(=O)O.C1CNCC(C2=CC(=C(C(=C21)Cl)O)O)C3=CC=C(C=C3)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	BZQ2I3	Atorvastatin calcium	Investigative	60822	C66H68CaF2N4O10	1155.3	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)[O-])O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4.CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)[O-])O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4.[Ca+2]	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D00RFY	DIOSMETIN	Investigative	5281612	C16H12O6	300.26	COC1=C(C=C(C=C1)C2=CC(=O)C3=C(C=C(C=C3O2)O)O)O	IC50 ~ 50000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D01FGM	CHRYSOERIOL	Investigative	5280666	C16H12O6	300.26	COC1=C(C=CC(=C1)C2=CC(=O)C3=C(C=C(C=C3O2)O)O)O	IC50 ~ 50000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D01OIK	xamoterol	Investigative	155774	C16H25N3O5	339.39	C1COCCN1C(=O)NCCNCC(COC2=CC=C(C=C2)O)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D03IRR	Phenazone	Investigative	2206	C11H12N2O	188.23	CC1=CC(=O)N(N1C)C2=CC=CC=C2	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D07GXY	piribedil	Investigative	4850	C16H18N4O2	298.34	C1CN(CCN1CC2=CC3=C(C=C2)OCO3)C4=NC=CC=N4	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D08CNS	IPRONIAZIDE	Investigative	3748	C9H13N3O	179.22	CC(C)NNC(=O)C1=CC=NC=C1	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D09XCX	PIRINIXIC ACID	Investigative	5694	C14H14ClN3O2S	323.8	CC1=C(C(=CC=C1)NC2=CC(=NC(=N2)SCC(=O)O)Cl)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0B1PH	Oxymethalone	Investigative	5281034	C21H32O3	332.5	C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C)O)CC[C@@H]4[C@@]3(C/C(=C/O)/C(=O)C4)C	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0D8RC	Metformin	Investigative	4091	C4H11N5	129.16	CN(C)C(=N)N=C(N)N	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0F5LH	Oxybutynine	Investigative	4634	C22H31NO3	357.5	CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0J6JT	m-chlorophenylpiperazine	Investigative	1355	C10H13ClN2	196.67	C1CN(CCN1)C2=CC(=CC=C2)Cl	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0K2KR	Eplerenone	Investigative	443872	C24H30O6	414.5	C[C@]12CCC(=O)C=C1C[C@H]([C@@H]3[C@]24[C@H](O4)C[C@]5([C@H]3CC[C@@]56CCC(=O)O6)C)C(=O)OC	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0KN6Q	3R14S-OCHRATOXIN A	Investigative	442530	C20H18ClNO6	403.8	C[C@@H]1CC2=C(C=C(C(=C2C(=O)O1)O)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)O)Cl	IC50 = 58000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0RN5A	[3H]naloxone	Investigative	5284596	C19H21NO4	327.4	C=CCN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)O)O4)O	IC50 = 133000 nM	Poor binder
T61792	Multidrug resistance-associated protein 2	D0UK7Z	Emetine hydrochloride	Investigative	10219	C29H40N2O4	480.6	CC[C@H]1CN2CCC3=CC(=C(C=C3[C@@H]2C[C@@H]1C[C@@H]4C5=CC(=C(C=C5CCN4)OC)OC)OC)OC	IC50 = 133000 nM	Poor binder